Sovaldi | pharmaphorum

Sovaldi

News

Blood sample with respiratory coronavirus positive

Could Gilead's Sovaldi be the answer to COVID-19 coronavirus...

A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investiga

News

Gilead Sciences

Gilead needs deal-maker CEO after Milligan quits

Gilead may be looking for a deal-broker who can kick-start the company’s growth after the lacklustre launch of its CAR-T therapy, after CEO John Milligan announced he is to step down at the

News

Zepatier

Zepatier to add competition to Europe’s hep C market

Will company pursue same aggressive pricing strategy in Europe?

Views & Analysis

Epclusa is a pan-genotypic therapy, but won't counteract the trend

Many millions still untreated – but hep C boom is already ov...

Gilead has led a revolution in curing hepatitis C, but now faces a slowdown.

US

Epclusa is a pan-genotypic therapy, but won't counteract the trend

Gilead hopes cut-price pan-genomic hep C combo will revive s...

Epclusa is first treatment for all six major virus genotypes.

Articles

Gilead Sciences

Raising the bar: can Gilead’s next challenge be even bigger ...

How do you follow a genuine drug breakthrough, a cure for hepatitis C?